ResveratrolanimalAnimal model2020

Interactions between trans-resveratrol and CpLIP2 lipase/acyltransferase: Evidenced by fluorescence and in silico.

Food chemistry

confidence

Key findings

Trans-resveratrol binds to CpLIP2 catalytic site via electrostatic and hydrophobic forces; fluorescence quenching and competitive inhibition observed.

View source on PubMed (PMID 32145543) ↗

Sample size
Not reported
Population
In vitro (CpLIP2 from C. parapsilosis CBS 604 and trans-resveratrol)
Dosing
Not reported
Duration
Not reported
Route
In vitro
Blinding
not_reported
Controls
none
Drug class
polyphenol
Full abstract

We have examined the trans-resveratrol/lipase interaction by quantitative and qualitative analyses of fluorescence spectra, molecular docking and quantum-chemical calculations at DFT level. Interactions of CpLIP2 from C. parapsilosis CBS 604 and trans-resveratrol were confirmed with a major contribution of tryptophan residues to fluorescence quenching. A thermodynamic study across a wide temperature range was consistent with the presence of a single binding site with a binding free energy of -24 kJ/mol. Nevertheless, trans-resveratrol competitively inhibited CpLIP2 activity. Molecular docking and quantum-chemical calculations were consistent with a strong binding of trans-resveratrol to the CpLIP2 catalytic site via electrostatic and hydrophobic forces. The structural analysis quantitatively revealed an energy transfer from W51 and W350 to trans-resveratrol with a distance of 32 Å. Precise understanding of trans-resveratrol/CpLIP2 interactions has important implications on lipases for screening of stilbenoid.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.